Drug Profile
Research programme: tubulin polymerisation inhibitors - SALVAT
Alternative Names: SVT 4703; SVT004703Latest Information Update: 31 May 2010
Price :
$50
*
At a glance
- Originator SALVAT
- Class Imidazoles
- Mechanism of Action Tubulin polymerisation inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 06 Dec 2006 Preclinical trials in Cancer in Spain (unspecified route)